(Q40771213)

English

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

respiratory syncytial virus

0 references

RSV major surface glycoprotein G

0 references

author name string

Teng MN

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Whitehead SS

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Collins PL

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

number of pages

14

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

289

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

283-296

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Animal cell mutants defective in glycosaminoglycan biosynthesis

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Structure-function analysis of the Sendai virus F and HN cytoplasmic domain: different role for the two proteins in the production of virus particle

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase.

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor.

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Sendai virus-like particles devoid of haemagglutinin-neuraminidase protein infect cells via the human asialoglycoprotein receptor

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G.

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence.

1 reference

https://api.crossref.org/works/10.1006/VIRO.2001.1138

29 December 2022

Identifiers

10.1006/VIRO.2001.1138

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40771213&oldid=1906943515"